Career Center



  BioSF: "Biotech's Never-ending Hunger for Capital," Jason Kantor, PhD, Managing Director, RBC Capital Markets
Date:   Wednesday, January 19, 2011
Time:   6:00-9:00PM

The Clarion Hotel
401 East Millbrae Avenue
Millbrae, CA

Sponsor:   BioSF
Event details:  


Fueling innovation and drug development is not for the financial faint of heart. Even the straightest path is typically long and very expensive, and few projects go according to plan. The old model of stepwise funding at increased value between clinical stages no longer exists. With one eye on the future and the other looking in the rear view mirror, we will explore what is working and why.

6:00pm - Networking
7:00pm - Dinner
8:00pm - Presentation


Dr. Kantor joined RBC Capital Markets in 2005 as a managing director and senior biotechnology equity research analyst. Previously, he was a managing director and senior biotechnology analyst at WR Hambrecht + Co from 2002 to 2005, and vice president in equity research at J.P. Morgan Chase & Co from 1998 to 2002. Previous equity research assignments also include Salomon Smith Barney and Josephthal Lyon & Ross. Dr. Kantor's healthcare expertise covers several important categories including oncology, cardiology, antibody technology and infectious disease. Dr. Kantor has had several independent recognitions including: Fortune magazine "All-Star Analyst" in 2004, Wall Street Journal ranked him #2 in 2004 and #4 in 2010 in its "Best on Wall Street Survey," and the Financial Times and Starmine ranked him #2 for earnings estimations in 2010. Dr. Kantor received his B.A. cum laude in Biology from the University of California, San Diego and his Ph.D. in Cell and Developmental Biology from Harvard University.

Additional information and/or registration:  

Registration required. $45 full-time student on-site registration. More information available here.


Footer Links: